(Q43279104)

English

Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments

scientific article published on 23 January 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

author name string

Morten Løbner

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Robert G Q Leslie

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Wolfgang M Prodinger

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Claus H Nielsen

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

publication date

23 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

128

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

e661-9

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2009.03056.X

21 January 2018

Annexin V binds to positively selected B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2009.03056.X

21 January 2018

Terminal complement complex C5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

Inflammation, the complement system and the diseases of aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

Mechanisms of immune-deposit formation and the mediation of immune renal injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

The role of complement activation in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

Complement and autoimmune glomerular diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

Role of the C5b-9 complement complex in cell cycle and apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

A role for lipid rafts in B cell antigen receptor signaling and antigen targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

The future use of complement inhibitors for the treatment of neurological diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

B cells turn off virgin but not memory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

29 September 2018

The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753917

1 December 2018

The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19740327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The terminal complement complex C5b-9 stimulates interleukin-6 production in human smooth muscle cells through activation of transcription factors NF-kappa B and AP-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/19740327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The terminal complement complex inhibits apoptosis in vascular smooth muscle cells by activating an autocrine IGF-1 loop

1 reference

https://pubmed.ncbi.nlm.nih.gov/19740327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19740327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholera toxin: interaction of subunits with ganglioside GM1

1 reference

https://pubmed.ncbi.nlm.nih.gov/19740327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19740327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up-regulation of intracellular calcium, cyclic adenosine monophosphate and fibronectin synthesis in tubuar epithelial cells by complement

1 reference

https://pubmed.ncbi.nlm.nih.gov/19740327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19740327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2567.2009.03056.X

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43279104&oldid=1985521748"